DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $746,802 | +9.9% | 2,989 | +9.8% | 0.04% | +7.1% |
Q1 2024 | $679,738 | +14.6% | 2,722 | +6.2% | 0.04% | +5.0% |
Q4 2023 | $593,156 | -15.6% | 2,564 | -9.5% | 0.04% | -25.9% |
Q3 2023 | $703,116 | +23.8% | 2,834 | +19.7% | 0.05% | +25.6% |
Q2 2023 | $568,080 | +0.9% | 2,367 | +6.0% | 0.04% | -2.3% |
Q1 2023 | $562,805 | -10.8% | 2,233 | -6.1% | 0.04% | -17.0% |
Q4 2022 | $631,169 | -5.9% | 2,378 | -8.4% | 0.05% | -17.2% |
Q3 2022 | $671,000 | +28.3% | 2,596 | +25.8% | 0.06% | +30.6% |
Q2 2022 | $523,000 | +27.3% | 2,064 | +47.2% | 0.05% | +40.0% |
Q1 2022 | $411,000 | -47.7% | 1,402 | -41.3% | 0.04% | -50.0% |
Q4 2021 | $786,000 | +8.4% | 2,389 | +0.3% | 0.07% | -1.4% |
Q3 2021 | $725,000 | +16.9% | 2,382 | +3.2% | 0.07% | +14.5% |
Q2 2021 | $620,000 | +33.6% | 2,309 | +12.1% | 0.06% | +10.7% |
Q1 2021 | $464,000 | +7.7% | 2,060 | +6.1% | 0.06% | -11.1% |
Q4 2020 | $431,000 | +50.2% | 1,942 | +45.5% | 0.06% | +21.2% |
Q3 2020 | $287,000 | +34.7% | 1,335 | +10.6% | 0.05% | +13.0% |
Q2 2020 | $213,000 | +144.8% | 1,207 | +91.0% | 0.05% | +91.7% |
Q1 2020 | $87,000 | +55.4% | 632 | +74.6% | 0.02% | +50.0% |
Q4 2019 | $56,000 | +833.3% | 362 | +722.7% | 0.02% | +700.0% |
Q3 2019 | $6,000 | +20.0% | 44 | +37.5% | 0.00% | 0.0% |
Q2 2019 | $5,000 | – | 32 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |